Health Advisory: Shortage of Purified Protein Derivative (PPD) Solution for Tuberculin Skin Testing

Nancy Leveille and Lisa Volk in Clinical & Quality

On June 6, 2019 the Centers for Disease Control and Prevention issued a Health Advisory (CDC-HAN-00420) providing notification of an anticipated three to ten-month shortage of Aplisol ®, a product of Par Pharmaceuticals. At this time, there is availability of the other FDA-approved solution, Tubersol ®, a product of Sanofi Pasteur. Please distribute to the Chief Medical Officer, Infection Control Department, Infectious Disease Department, Director of Nursing, AND Primary Care Clinics. See attached for full advisory.

NYSHFA/NYSCAL CONTACTS:

Nancy Leveille, RN, MS
Executive Director
518-462-4800 x20

Lisa Volk, RN, B.P.S., LNHA
Director, Clinical & Quality Services
462-4800 x15